Viking Therapeutics shares fall 40% on disappointing obesity pill trial data
Shares of Viking Therapeutics fell 40% on Tuesday after the company released mid-stage trial data on its obesity pill that ...
Shares of Viking Therapeutics fell 40% on Tuesday after the company released mid-stage trial data on its obesity pill that ...
Cr | Istock | Getty ImagesBiotech company Viking Therapeutics has emerged as a strong potential entrant — or takeover target ...
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or ...
© 2024 LSD News title="Jegtheme">Jegtheme.